<?xml version="1.0" encoding="utf-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd"><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55417212/phillips-medisize-expands-uk-inhalation-manufacturing-footprint</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-06T15:22:05.000Z</news:publication_date><news:title>Phillips Medisize expands UK inhalation manufacturing footprint</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55417215/pharmala-picks-corealis-for-gmp-manufacturing-of-drug-candidate</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-06T15:13:22.000Z</news:publication_date><news:title>PharmAla picks Corealis for GMP manufacturing of drug candidate</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55416990/samsung-biologics-moves-closer-to-18b-polypeptide-deal</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-05T17:01:17.000Z</news:publication_date><news:title>Samsung Biologics moves closer to $1.8B PolyPeptide deal</news:title></news:news></url><url><loc>https://www.pharmamanufacturing.com/industry-news/news/55416984/vintabios-assets-for-sale-including-philadelphia-gmp-site</loc><news:news><news:publication><news:name>Pharma Manufacturing</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-05T16:56:06.000Z</news:publication_date><news:title>VintaBio’s assets for sale, including Philadelphia GMP site</news:title></news:news></url></urlset>